In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease.
AUTOR(ES)
Cohen, M L
RESUMO
To determine which cells within the brain produce beta-amyloid mRNA and to assess expression of the beta-amyloid gene in Alzheimer disease, we analyzed brain tissue from Alzheimer and control patients by in situ hybridization. Our results demonstrate that beta-amyloid mRNA is produced by neurons in the nucleus basalis of Meynert and cerebral cortex and that nucleus basalis perikarya from Alzheimer patients consistently hybridize more beta-amyloid probe than those from controls. These observations support the hypothesis that increased expression of the beta-amyloid gene plays an important role in the deposition of amyloid in the brains of patients with Alzheimer disease.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=279740Documentos Relacionados
- Beta-amyloid gene dosage in Alzheimer's disease.
- Complement activation by beta-amyloid in Alzheimer disease.
- Decreased choline acetyltransferase mRNA expression in the nucleus basalis of Meynert in Alzheimer disease: an in situ hybridization study.
- Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts.
- Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells.
